Immunity gene therapeutic technologies predicted market dominance in 10 years.

Published: 2004-05-19 06:57:00

Updated: 2004-05-19 06:57:00

A bio technology expert predicted that the immunity gene therapy would be recognized as a leading therapeutic technology in coming years, and so important that its provisional ground and infrastructure should be built up as early as possible.

Director Sohn Jong-moon of Genexin Co. reported in the latest Spring issue of "Health Industry Technology Trend" that a vaccine production is one of th...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.